Zobrazit v EDS

Bioactive Potential and In silico Insights of Flavonoid-Enriched Femivine V Jelly and Kaempferia Angustifolia Extracts in Antioxidant and Anticancer Applications.

Uloženo v:
Podrobná bibliografie
Název: Bioactive Potential and In silico Insights of Flavonoid-Enriched Femivine V Jelly and Kaempferia Angustifolia Extracts in Antioxidant and Anticancer Applications.
Autoři: MOHD FAZIL, FARAH NADIAH, ZUBAIRI, SAIFUL IRWAN, KASIM, ZALIFAH MOHD, RAJIKAN, ROSLEE, MOHAMED, ISA NAINA, ZAKARIA, IKHWAN, SA'AIDIN, MOHD FAIZAL
Zdroj: Current Research in Nutrition & Food Science; Aug2025, Vol. 13 Issue 2, p861-875, 15p
Témata: PHENOL analysis, COMPUTER simulation, ADENOCARCINOMA, LIQUID chromatography-mass spectrometry, RESEARCH funding, FLAVONOIDS, ANTINEOPLASTIC agents, BREAST tumors, PHYTOCHEMICALS, IMMUNODIAGNOSIS, PLANT extracts, CELL lines, ANTIOXIDANTS, RESEARCH, ORGANIC compounds, COMPARATIVE studies, FREE radicals, CELL surface antigens, PHARMACODYNAMICS
Abstrakt: Kaempferia angustifolia, a notable medicinal herb within the ginger family, comprises around 60 species of rhizomatous plants. Commonly referred to as temu kunci, kunci pepet, or Thao Nhang Haeng in Southeast Asia, it is renowned for its aromatic rhizomes, traditionally utilized to address ailments like colds, digestive issues, and fevers. Recent research underscores its potential in cancer chemoprevention, alongside antioxidants, antimicrobial, anti-obesity, and anti-allergic properties. This study focuses on four key flavonoids found in the innovative FemiVine V jelly product and the raw extract of the Kaempferia angustifolia plant. The jelly exhibited a 60% higher total phenolic content (31.93 ± 0.20 mg/g) compared to the raw extract (12.0 ± 0.23 mg/g, p<0.05). Antioxidant assays revealed superior DPPH radical scavenging activity in the jelly (67.6 ± 0.15%) versus the extract (30.54 ± 0.10%, p<0.05), supported by FRAP values of 5.08 ± 0.01 mg/100 g (jelly) and 4.81 ± 0.05 mg/100 ml (extract). Cytotoxic screening against MDA-MB-231 breast cancer cells showed stronger activity in the raw extract (IC50: 82 ± 0.06 mg/ml) compared to the jelly (IC50: 125 ± 0.20 mg/ml, p<0.05). In-silico analysis highlighted vitexin and β-sitosterol as promising candidates for peripheral cancer treatment due to favorable pharmacokinetic properties, including gastrointestinal absorption and lack of brain penetration. Further research is needed to assess their selective cytotoxicity against cancer cells versus normal fibroblasts. [ABSTRACT FROM AUTHOR]
Copyright of Current Research in Nutrition & Food Science is the property of Current Research in Nutrition & Food Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Databáze: Complementary Index
Popis
Abstrakt:Kaempferia angustifolia, a notable medicinal herb within the ginger family, comprises around 60 species of rhizomatous plants. Commonly referred to as temu kunci, kunci pepet, or Thao Nhang Haeng in Southeast Asia, it is renowned for its aromatic rhizomes, traditionally utilized to address ailments like colds, digestive issues, and fevers. Recent research underscores its potential in cancer chemoprevention, alongside antioxidants, antimicrobial, anti-obesity, and anti-allergic properties. This study focuses on four key flavonoids found in the innovative FemiVine V jelly product and the raw extract of the Kaempferia angustifolia plant. The jelly exhibited a 60% higher total phenolic content (31.93 ± 0.20 mg/g) compared to the raw extract (12.0 ± 0.23 mg/g, p<0.05). Antioxidant assays revealed superior DPPH radical scavenging activity in the jelly (67.6 ± 0.15%) versus the extract (30.54 ± 0.10%, p<0.05), supported by FRAP values of 5.08 ± 0.01 mg/100 g (jelly) and 4.81 ± 0.05 mg/100 ml (extract). Cytotoxic screening against MDA-MB-231 breast cancer cells showed stronger activity in the raw extract (IC<subscript>50</subscript>: 82 ± 0.06 mg/ml) compared to the jelly (IC<subscript>50</subscript>: 125 ± 0.20 mg/ml, p<0.05). In-silico analysis highlighted vitexin and β-sitosterol as promising candidates for peripheral cancer treatment due to favorable pharmacokinetic properties, including gastrointestinal absorption and lack of brain penetration. Further research is needed to assess their selective cytotoxicity against cancer cells versus normal fibroblasts. [ABSTRACT FROM AUTHOR]
ISSN:2347467X
DOI:10.12944/CRNFSJ.13.2.22